
NCPA Urges Swift Congressional Action on ‘Any Willing Pharmacy' Legislation
PRESS RELEASE
ALEXANDRIA, Va. (August 7, 2014) — Key congressional committee leaders were encouraged today to hold hearings on “any willing pharmacy” legislation by the National Community Pharmacists Association.
In
In a
“Most stakeholders would agree that Part D has been a success,” NCPA CEO B. Douglas Hoey, RPh, MBA, wrote in the letters, “but with any law comes unintended consequences, and we know that Congress did not intend to create access problems or limit choice for Medicare patients who depend on the face-to-face counseling services that independent pharmacies have offered them for many years.” Mr. Hoey continued, “Again, we respectfully request that you schedule an oversight hearing after the Congressional Work Period has concluded to examine ways to ensure that small business owner pharmacies have the same opportunities to compete in the Medicare Part D program as do larger, corporate pharmacies.”
Support for “any willing pharmacy” legislation continues to grow. For example H.R. 4577 is
Learn more at
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.